Skip to main content
Log in

L’ipotiroidismo congenito

  • RASSEGNA
  • Published:
L'Endocrinologo Aims and scope

Sommario

L’ipotiroidismo congenito (IC) è la più frequente patologia endocrina presente alla nascita. Un ritardo nella diagnosi o nel trattamento possono provocare disturbi dell’accrescimento o disturbi neuropsicologici, che possono essere prevenuti da un tempestivo inizio della terapia sostitutiva con L-Tiroxina entro le prime 2 settimane dopo la nascita. La diagnosi precoce viene eseguita alla nascita mediante la misura di TSH o TSH e T4 su spot. Dopo una conferma di IC con dosaggio di FT4 e TSH su siero, la terapia con L-tiroxina dovrebbe essere iniziata immediatamente. Altri esami diagnostici come l’ecografia e la scintigrafia tiroidea possono essere utlizzati per la definizione della causa di IC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Bibliografia

  1. Léger J, Olivieri A, Donaldson M et al. (ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE; Congenital Hypothyroidism Consensus Conference Group) (2014) European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab 99(2):363–384

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bongers-Schokking JJ, de Muinck Keizer-Schrama SMPF (2005) Influence and timing of the dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism. J Pediatr 147:768–774

    Article  CAS  PubMed  Google Scholar 

  3. Corbetta C, Weber G, Cortinovis F et al. (2009) A 7-year experience with low blood TSH cutoff levels for neonatal screening reveals an unsuspected frequency of congenital hypothyroidism (CH). Clin Endocrinol 71(5):739–745

    Article  CAS  Google Scholar 

  4. De Felice M, Di Lauro R (2004) Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 25(5):722–746

    Article  CAS  PubMed  Google Scholar 

  5. Grasberger H, Refetoff S (2011) Genetic causes of congenital hypothyroidism due to dyshormonogenesis. Curr Opin Pediatr 23(4):421–428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. De Marco G, Agretti P, Montanelli L et al. (2011) Identification and functional analysis of novel dual oxidase 2 (DUOX2) mutations in children with congenital or subclinical hypothyroidism. J Clin Endocrinol Metab 96(8):1335–1339

    Article  CAS  Google Scholar 

  7. Gaudino R, Garel C, Czernichow P, Léger J (2005) Proportion of various types of thyroid disorders among newborns with congenital hypothyroidism and normally located gland: a regional cohort study. Clin Endocrinol 62(4):444–448

    Article  Google Scholar 

  8. Beck-Peccoz P, Rodari G, Giavoli C, Lania A (2017) Central hypothyroidism—a neglected thyroid disorder. Nat Rev Endocrinol 13(10):588–598

    Article  CAS  PubMed  Google Scholar 

  9. Olivieri A, Stazi MA, Mastroiacovo P et al. (Study Group for Congenital Hypothyroidism) (2002) A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991–1998). J Clin Endocrinol Metab 87(2):557–562

    CAS  PubMed  Google Scholar 

  10. Italian National Registry of Infants with Congenital Hypothyroidism (INRICH). http://www.iss.it/rnic/. Accessed February 8, 2013

  11. Hrytsiuk I, Gilbert R, Logan S et al. (2002) Starting dose of levothyroxine for the treatment of congenital hypothyroidism: a systematic review. Arch Pediatr Adolesc Med 146:485–491

    Article  Google Scholar 

  12. Peroni E, Vigone MC et al. (2014) Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Horm Res Paediatr 81(1):50–54

    Article  CAS  PubMed  Google Scholar 

  13. Salerno M, Micillo M, Di Maio S et al. (2001) Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol 145(4):377–383

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Massimo Tonacchera.

Ethics declarations

Conflitto di interesse

Gli autori Massimo Tonacchera, Tommaso Aversa e Filippo De Luca dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Additional information

Proposto da Andrea Lania.

Materiale elettronico supplementare

I link al materiale elettronico supplementare sono elencati qui sotto.

(DOC 51 kB)

(DOC 47 kB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tonacchera, M., Aversa, T. & De Luca, F. L’ipotiroidismo congenito. L'Endocrinologo 20, 121–126 (2019). https://doi.org/10.1007/s40619-019-00580-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-019-00580-7

Parole chiave

Navigation